These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12370268)

  • 21. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sigma-1 receptor-induced increase in murine spinal NR1 phosphorylation is mediated by the PKCalpha and epsilon, but not the PKCzeta, isoforms.
    Roh DH; Yoon SY; Seo HS; Kang SY; Moon JY; Song S; Beitz AJ; Lee JH
    Neurosci Lett; 2010 Jun; 477(2):95-9. PubMed ID: 20417251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice.
    Kita A; Furukawa K
    Pharmacol Biochem Behav; 2008 Apr; 89(2):171-8. PubMed ID: 18201755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala.
    Femenía T; Pérez-Rial S; Urigüen L; Manzanares J
    J Psychopharmacol; 2011 Jan; 25(1):87-96. PubMed ID: 20530587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
    Reynolds DS
    Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors.
    Pierrefiche G; Zerbib R; Laborit H
    Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):131-42. PubMed ID: 7905658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.
    Martin JR; Pieri L; Bonetti EP; Schaffner R; Burkard WP; Cumin R; Haefely WE
    Pharmacopsychiatry; 1988 Nov; 21(6):360-2. PubMed ID: 2907644
    [No Abstract]   [Full Text] [Related]  

  • 29. Anxiety at the frontier of molecular medicine.
    Weinberger DR
    N Engl J Med; 2001 Apr; 344(16):1247-9. PubMed ID: 11309643
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein kinase C: molecular and cellular targets for the action of ethanol.
    Pandey SC
    Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):67A-71A. PubMed ID: 8947238
    [No Abstract]   [Full Text] [Related]  

  • 31. Neural and molecular mechanisms in anxiety.
    Wolkowitz OM; Paul SM
    Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex.
    Seo JJ; Lee SH; Lee YS; Kwon BM; Ma Y; Hwang BY; Hong JT; Oh KW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1363-9. PubMed ID: 17698274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurobiological approach to anxiety].
    Boyer P
    Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():43-6. PubMed ID: 2889436
    [No Abstract]   [Full Text] [Related]  

  • 34. Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.
    Wu D; Foreman TL; Gregory CW; McJilton MA; Wescott GG; Ford OH; Alvey RF; Mohler JL; Terrian DM
    Cancer Res; 2002 Apr; 62(8):2423-9. PubMed ID: 11956106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The mechanism of action of benzodiazepine and its consequences for therapy].
    Cugurra F
    Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
    García-Gutiérrez MS; Manzanares J
    J Psychopharmacol; 2011 Jan; 25(1):111-20. PubMed ID: 20837564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches to developing new anxiolytics and antidepressants.
    Dubovsky SL
    J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
    Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
    J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K+ channel TASK-1 knockout mice show enhanced sensitivities to ataxic and hypnotic effects of GABA(A) receptor ligands.
    Linden AM; Aller MI; Leppä E; Rosenberg PH; Wisden W; Korpi ER
    J Pharmacol Exp Ther; 2008 Oct; 327(1):277-86. PubMed ID: 18660435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in clinical treatment of anxiety disorders].
    Yu Z; Yian H
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr; 25(2):116-9. PubMed ID: 1354152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.